Related Experiment Video
Updated: Jun 25, 2025
Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
Profiling complex repeat expansions in RFC1 in Parkinson's disease
Pilar Alvarez Jerez1,2,3, Kensuke Daida1,2, Abigail Miano-Burkhardt1,2
1Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA.
A biallelic expansion in the RFC1 gene is linked to cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS). This study found RFC1 expansions in four non-Finnish European Parkinson
Area of Science:
- Neurogenetics
- Neurology
- Genomics
Background:
- A biallelic (AAGGG) expansion in the RFC1 gene's AluSx3 element is a known cause of CANVAS.
- This RFC1 expansion has been identified as a rare cause of Parkinson's disease (PD) in Finland.
Purpose of the Study:
- To investigate the prevalence of RFC1 (AAGGG) expansions in non-Finnish European Parkinson's disease patients.
- To determine if RFC1 expansions are a significant genetic factor in PD in this population.
Main Methods:
- Analysis of 1609 individuals from the Parkinson's Progression Markers Initiative (PPMI) study.
- Genetic testing for biallelic (AAGGG) expansions in the RFC1 gene.
Main Results:
- Four Parkinson's disease patients of non-Finnish European ancestry were found to carry the biallelic RFC1 (AAGGG) expansion.
- No carriers of the RFC1 expansion were identified in the control group within the study cohort.
Conclusions:
- The RFC1 (AAGGG) expansion is present in a subset of Parkinson's disease patients of non-Finnish European descent.
- This finding suggests RFC1 expansions may contribute to Parkinson's disease pathogenesis beyond the Finnish population.
More Related Videos
05:22Author Spotlight: Characterizing DNA Replication of Pathogenic Repeats to Uncover Mechanisms of Replication Fork Stalling and Expansion
Published on: September 13, 2024
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
